Clinical Trials Directory

Trials / Completed

CompletedNCT07017088

Efficacy of Leuconostoc Mesenteroides

A Randomized Crossover Trial on the Efficacy of Leuconostoc Mesenteroides (VITA-PB2) From Kimchi in Relieving Hangover Symptom

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
28 (actual)
Sponsor
Wonju Severance Christian Hospital · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

Excessive alcohol intake can cause dehydration, digestive issues, oxidative stress, and hangover symptoms like headache and fatigue. Toxic metabolites like acetaldehyde and ROS contribute to liver damage. Chronic drinking activates harmful pathways like MEOS and increases inflammation. Gut-liver axis disruption also worsens hangovers. Probiotics, such as Leuconostoc mesenteroides, may help restore gut health and reduce toxicity, but more clinical research is needed.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTLeuconostoc mesenteroidesControl vs Experiment

Timeline

Start date
2024-08-13
Primary completion
2024-09-13
Completion
2025-02-28
First posted
2025-06-12
Last updated
2025-06-12

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT07017088. Inclusion in this directory is not an endorsement.

Efficacy of Leuconostoc Mesenteroides (NCT07017088) · Clinical Trials Directory